From Data to Impact: Real-World Evidence Transforming Obesity & Cardiometabolic Care
- Leveraging RWE to accelerate drug development with a lifecycle lens
- Exploring treat-to-target paradigms and patient-centric endpoints to enhance reimbursement potential
- Looking beyond trials by using RWE to identify high-risk populations and support precision medicine to accelerate market access